Yoshio Ikeda

Yoshio Ikeda

Auto-generated profile, based on publicly available information

Yoshio Ikeda

Endoscopy Center, Ehime University Hospital Toon Ehime Japan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2018 in JMIR Mental Health
Verified
Journal Article
Open access
TFToshi A Furukawa
Toshi A Furukawa
MHMasaru Horikoshi
Masaru Horikoshi
HFHirokazu Fujita
Hirokazu Fujita
NTNaohisa Tsujino
Naohisa Tsujino
RJRan Jinnin
Ran Jinnin
AHAkio Hasegawa
Akio Hasegawa
Background: A strong and growing body of evidence has demonstrated the effectiveness of cognitive behavioral therapy (CBT), either face-to-face, in person, or as self-help via the Internet, for depression. However, CBT is a complex intervention consisting of several putatively effective components, and how each component may or may not contribute to the overall effectiveness of CBT is poorly understood. Objective: The aim of this study was to investigate how the users of smartphone CBT use and benefit from various components of the program. Methods: This is a secondary analysis from a 9-week, single-blind, randomized controlled trial that has demonstrated the effectiveness of adjunctive use of smartphone CBT (Kokoro-App) over antidepressant pharmacotherapy alone among patients with drug-resistant major depressive disorder (total n=164, standardized mean difference in depression severity at week 9=0.40, J Med Internet Res). Kokoro-App consists of three cognitive behavioral skills of self-monitoring, behavioral activation, and cognitive restructuring, with corresponding worksheets to fill in. All activities of the participants learning each session of the program and completing each worksheet were uploaded onto Kokoro-Web, which each patient could use for self-check. We examined what use characteristics differentiated the more successful users of the CBT app from the less successful ones, split at the median of change in depression severity. Results: A total of 81 patients with major depression were allocated to the smartphone CBT. On average, they completed 7.0 (standard deviation [SD] 1.4) out of 8 sessions of the program; it took them 10.8 (SD 4.2) days to complete one session, during which they spent 62 min (SD 96) on the app. There were no statistically significant differences in the number of sessions completed, time spent for the program, or the number of completed self-monitoring worksheets between the beneficiaries and the nonbeneficiaries. However, the former completed more behavioral activation tasks, engaged in different types of activities, and also filled in more cognitive restructuring worksheets than the latter. Activities such as “test-drive a new car,” “go to a coffee shop after lunch,” or “call up an old friend” were found to be particularly rewarding. All cognitive restructuring strategies were found to significantly decrease the distress level, with “What would be your advice to a friend who has a similar problem?” found more helpful than some other strategies. Conclusions: The CBT program offered via smartphone and connected to the remote server is not only effective in alleviating depression but also opens a new avenue in gathering information of what and how each participant may utilize the program. The activities and strategies found useful in this analysis will provide valuable information in brush-ups of the program itself and of mobile health (mHealth) in general. Trial Registration: Japanese Clinical Trials Registry UMIN CTR 000013693; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ ctr_view.cgi?recptno=R000015984 (Archived by WebCite at http://www.webcitation.org/6u6pxVwik)

1 July 2001 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
PDF file
ASAtsuko Sasaki
Atsuko Sasaki
AKAtsuko Kurisu
Atsuko Kurisu
MOMakoto Ohno
Makoto Ohno
YIYoshio Ikeda
Yoshio Ikeda

19 January 2022 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
YYYasunori Yamamoto
Yasunori Yamamoto
Shinya FurukawaShinya Furukawa
Shinya Furukawa
JWJunichi Watanabe
Junichi Watanabe
TMTeruki Miyake
Teruki Miyake
AKAki Kato
Aki Kato
YHYoichi Hiasa
Yoichi Hiasa

11 October 2020 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
KSKana Shiraishi
Kana Shiraishi
Shinya FurukawaShinya Furukawa
Shinya Furukawa
SYSen Yagi
Sen Yagi
MHMasakazu Hanayama
Masakazu Hanayama
KMKenichirou Mori
Kenichirou Mori
YHYoichi Hiasa
Yoichi Hiasa

30 April 2023 in Annals of Coloproctology
Verified
Journal Article
Open access
PDF file
SYSen Yagi
Sen Yagi
Shinya FurukawaShinya Furukawa
Shinya Furukawa
KSKana Shiraishi
Kana Shiraishi
TMTeruki Miyake
Teruki Miyake
KTKazuhiro Tange
Kazuhiro Tange
YHYoichi Hiasa
Yoichi Hiasa
Purpose: The albumin to globulin ratio (AGR) is a recognized chronic inflammation marker. No evidence regarding the relationship between AGR level and ulcerative colitis (UC) exists. The aim of this study was to evaluate the association between AGR and clinical outcomes among Japanese subjects with UC.Methods: The study subjects consisted of 273 Japanese individuals with UC. AGR was divided into 4 categories (low, moderate, high, and very high). The definition of complete mucosal healing (MH) was based on the Mayo endoscopic subscore of 0. Clinical remission (CR) was defined as no rectal bleeding and no abnormally high stool frequency (<3 times per day).Results: The percentage of MH was 26.4%. High AGR and very high AGR were significantly positively correlated with CR (adjusted odds ratio [OR], 5.85; 95% confidence interval [CI], 2.52–14.18 and adjusted OR, 4.97; 95% CI, 2.14–12.04) and complete MH (adjusted OR, 4.03; 95% CI, 1.56–11.51 and adjusted OR, 5.22; 95% CI, 1.97–14.89), respectively after adjustment for confounding factors (P for trend=0.001). Only in the low C-reactive protein (CRP) group (≤0.1 mg/dL), very high AGR was significantly positively correlated with complete MH but not CR (adjusted OR, 4.38; 95% CI, 1.06–21.77; P for trend=0.017). In the high CRP group, no correlation between AGR and complete MH was found.Conclusion: Among Japanese patients with UC, AGR may be independently positively correlated with complete MH. In particular, among UC patients with low CRP, AGR might be a useful complementary marker for complete MH.

20 October 2022 in International Journal of Colorectal Disease
Verified
Journal Article
Closed access
PDF file
YYYasunori Yamamoto
Yasunori Yamamoto
Shinya FurukawaShinya Furukawa
Shinya Furukawa
JWJunichi Watanabe
Junichi Watanabe
AKAki Kato
Aki Kato
KKKatsunori Kusumoto
Katsunori Kusumoto
YHYoichi Hiasa
Yoichi Hiasa